Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01828346
Show Display Options
Rank Status Study
1 Completed Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine Therapy
Condition: Myelodysplastic Syndrome
Interventions: Drug: Birinapant;   Drug: 5-Azacitidine

Study has passed its completion date and status has not been verified in more than two years.